News on clinical details and treatment in PGM1-CDG

JIMD Reports

Volumn 26, Issue , 2016, Pages 77-84

  Schrapers, Esther ^a   Tegtmeyer, Laura C ^a   Simic Schleicher, Gunter ^b   Debus, Volker ^a   Reunert, Janine ^a   Balbach, Sebastian ^a   Klingel, Karin ^c   Du Chesne, Ingrid ^a   Seelhöfer, Anja ^a   Fobker, Manfred ^a   Marquardt, Thorsten ^a   Rust, Stephan ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b Klinikum Bremen Nord   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Aortic valve insufficiency; Glucagon test; Glycogen storage disease; Stabilize blood glucose; Transferrin isoforms

Indexed keywords

EID: 85026448001     PISSN: 21928304     EISSN: 21928312     Source Type: Book Series    
DOI: 10.1007/8904_2015_471     Document Type: Chapter

References (16)

1. Arimura T, Inagaki N et al (2009) Impaired binding of ZASP/Cypher with phosphoglucomutase 1 is associated with dilated cardiomyopathy. Cardiovasc Res 83(1):80–88
2. Biffi S, Tamaro G et al (2007) Carbohydrate-deficient transferrin (CDT) as a biochemical tool for the screening of congenital disorders of glycosylation (CDGs). Clin Biochem 40(18): 1431–1434
3. Dörre K, Olczak M et al (2015) A new case of UDP-galactose transporter deficiency (SLC35A2-CDG): molecular basis, clinical phenotype, and therapeutic approach. J Inherit Metab Dis. Epub ahead of print
4. Grundahl JE, Guan Z et al (2012) Life with too much polyprenol: polyprenol reductase deficiency. Mol Genet Metab 105(4): 642–651
5. Haller RG, Vissing J (2002) Spontaneous “second wind” and glucose-induced second “second wind” in McArdle disease: oxidative mechanisms. Arch Neurol 59(9):1395–1402
6. Helander A, Eriksson G et al (2001) Interference of transferrin isoform types with carbohydrate-deficient transferrin quantification in the identification of alcohol abuse. Clin Chem 47(7):1225–1233
7. Marquardt T, Denecke J (2003) Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapies. Eur J Pediatr 162(6):359–379
8. Mauras N, Attie KM et al (2000) High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group. J Clin Endocrinol Metab 85(10):3653–3660
9. Miller BS, Duffy MM et al (2013) Therapy for Growth Failure and IGF-1 Deficiency in Congenital Disorder of Glycosylation Ia (PMM2 Deficiency). J Investigative Med 2013(1):1–4
10. Niehues R, Hasilik M et al (1998) Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy. J Clin Invest 101(7):1414–1420
11. Punn R, Obayashi DY et al (2012) Supine exercise echocardiographic measures of systolic and diastolic function in children. J Am Soc Echocardiogr 25(7):773–781
12. Schreml J, Durmaz B et al (2014) The missing “link”: an autosomal recessive short stature syndrome caused by a hypofunctional XYLT1 mutation. Hum Genet 133(1):29–39
13. Tanaka C, Murata M et al (2004) Reference charts of body proportion for Japanese girls and boys. Ann Hum Biol 31(6): 681–689
14. Tegtmeyer LC, Rust S et al (2014) Multiple phenotypes in phosphoglucomutase 1 deficiency. N Engl J Med 370(6): 533–542
15. Tsintzas K, Simpson EJ et al (2003) Effect of exercise mode on blood glucose disposal during physiological hyperinsulinaemia in humans. Eur J Appl Physiol 89(2):217–220
16. Vatta M, Mohapatra B et al (2003) Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J Am Coll Cardiol 42(11):2014–2027